Molecular pathways: hypoxia response in immune cells fighting or promoting cancer
about
Remodeling Components of the Tumor Microenvironment to Enhance Cancer TherapyTargeting the tumor vasculature to enhance T cell activityc-Src and neural Wiskott-Aldrich syndrome protein (N-WASP) promote low oxygen-induced accelerated brain invasion by gliomasRelationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancerAntiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.Hypoxia Inducible Factor 1: A Urinary Biomarker of Kidney DiseaseThe polymorphic and contradictory aspects of intermittent hypoxiaIncreased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patientsGenome-wide hypermethylation coupled with promoter hypomethylation in the chorioamniotic membranes of early onset pre-eclampsia.The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanomaGenome-scale hypomethylation in the cord blood DNAs associated with early onset preeclampsiaReprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma.Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism.Vascular normalization as an emerging strategy to enhance cancer immunotherapy.Gold Nanoparticle-Mediated Targeted Delivery of Recombinant Human Endostatin Normalizes Tumour Vasculature and Improves Cancer Therapy.Prognostic value of peritumoral heat-shock factor-1 in patients receiving resection of hepatocellular carcinoma.Toll-like receptors in prostate infection and cancer between bench and bedsideImmunotherapy following regional chemotherapy treatment of advanced extremity melanomaThe Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma.Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea.Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer.Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma.Obstructive sleep apnea and cancer: Epidemiologic links and theoretical biological constructs.Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response.Deciphering and reversing tumor immune suppression.Antiangiogenic therapy improves the antitumor effect of adoptive cell immunotherapy by normalizing tumor vasculature.Isolated limb infusion as a model to test new agents to treat metastatic melanoma.Thrombocytosis as a prognostic marker in gastrointestinal cancers.Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment.Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer.Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.AMPK in lymphocyte metabolism and function.Role of inflammatory infiltrates in triple negative breast cancer.A stressful microenvironment: opposing effects of the endoplasmic reticulum stress response in the suppression and enhancement of adaptive tumor immunity.Hypoxic Modulation of HLA-G Expression through the Metabolic Sensor HIF-1 in Human Cancer CellsHypoxia Modulates the Response of Mast Cells to Staphylococcus aureus Infection.Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model.
P2860
Q26777144-AA7CAF83-CBE9-44FC-B585-640947DD7BC3Q27026329-C92324FD-DC6B-42F8-9677-854D8D27856FQ27305310-0285656E-E55A-4B6A-8460-BBF8E9438FA8Q28068654-A0BDDCCD-196E-4368-81F3-685C61AB464EQ30399006-9B294304-9489-40F4-A83E-4C21AF3B98CCQ33648040-097B6939-4B08-41C7-B6C7-B6FE5950423EQ33913792-BA27647B-63CA-4972-8C6E-5A2FA3041696Q34029008-0E053B75-8263-4A76-AA7A-D09484885E09Q34040496-F7C80E17-D674-4032-BBD5-FA5E32CF6DA2Q34459058-72350E65-F218-4AAB-A12C-DA068FCFC0A6Q35212170-99106D8C-CDFD-426A-884B-5D4D4AD81256Q35799094-1048D4F1-C863-40FE-8654-C84453064BD0Q36161453-B267E012-7055-4DA4-AA2C-A6D1B5CAC346Q36597479-51A4D3CA-F0DA-4116-9542-6535288E5F02Q36847357-D88AE372-1E6A-4805-B767-1C605034F73CQ37137190-F2C3178D-1FB1-477B-A537-909859E45707Q37182260-4A0A43D6-E44A-4769-8B1F-06AF45ED193AQ37295411-4DE91508-991B-4E58-9112-0696C7755D7DQ37509709-90802DEC-A231-464E-93CD-E733F6525EADQ37516448-6B0B64D0-A697-40BC-AAF7-A66CB38BEC90Q37566921-5FFF326B-6F28-4371-B043-15D76534CE77Q37688491-B3E06600-F15C-41B3-8E65-3AA9BE0CBABBQ37702665-39100014-DD10-4FD5-9B55-F843219FE293Q37710877-1E941E89-660A-4ED1-8CC1-7ABBCAB53EAFQ37731479-BD22FBCD-5594-4529-A3EF-53468BC0770EQ38019412-50866CD1-4A8C-4C43-9C5F-6E97F49081B5Q38098095-F1A36D77-A40F-472C-A4B5-4C9E4791A06DQ38124437-4B0390E4-C046-445C-A78B-F2990899CFE4Q38132055-2ED80624-AB18-4923-95D1-838881211208Q38187595-A4FE792A-0433-4568-BE35-FAD456B4EBD3Q38190956-C0576D04-E4F7-4768-B340-3844665D1EA6Q38218127-6903A73A-7A37-4692-B024-B594D2F3DE9AQ38223419-0810C1E5-D207-42A1-8B64-786E3CF9590FQ38246724-E7BC7848-7177-491B-B341-C1D1BAF1D563Q38264144-C2A1E2CD-0972-4D20-9F43-CE32186F8AE9Q38370266-47403ACC-B421-40A3-A0E1-68FD97B3F360Q38379620-6760DBD0-4301-4E50-8E34-5B6E8F876E8FQ38637836-A26D7C29-C800-4619-9A3F-5A76149A7F37Q38758968-75F69B86-8060-4575-859C-54094E64EB87Q38765125-2BB27D89-4425-4BE9-9220-5E82AD16F97D
P2860
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer
@ast
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer
@en
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer
@nl
type
label
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer
@ast
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer
@en
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer
@nl
prefLabel
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer
@ast
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer
@en
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer
@nl
P2093
P3181
P1476
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer
@en
P2093
Aizea Morales-Kastresana
Ignacio Melero
Manuel Ortiz de Landázuri
P304
P3181
P356
10.1158/1078-0432.CCR-11-1591
P407
P577
2011-12-28T00:00:00Z